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Abstract 
Introduction: The immune system is known to play a key role in the development of viral-induced wheeze, but the pattern of 
cytokine response is not clear. The aim of the study was to determine whether plasma cytokine levels during the acute wheezing 
illness in infants are associated with the subsequent development of persistent recurrent wheezing (PRW). 
Material and methods: 43 infants admitted to Iashvili Central Children Hospital, Tbilisi, Georgia, were selected. The concentra-
tions of IFN-g, TNF-a and IL-6 were determined by enzyme-linked immunosorbent assay (ELISA). Total serum IgE level was also 
determined. IgM and IgG antibodies to RSV, Chlamydophila pneumonia and Mycoplasma pneumonia were tested by ELISA. All 
children were followed-up during 3 years period.
Results: There was no significant association with PRW and atopy in the infant or parental atopy, low maternal age, low birth 
weight, serum level of IL-6, serum level of IFN-g, serum level of total IgE and the particular pathogen. There was a tendency for 
the association with male sex, bottle feeding and household cigarette smoking, although the relation was not significant. There 
was just TNF-a which was strongly associated with the risk of PRW after three years of follow up. 
Conclusion: We have identified TNF-a, as a biomarker, which can be detected in children under 3 years of age and may be useful 
in the prediction of development of persistence of wheezing later. To further evaluate the usefulness of this and other markers and 
establish cutoff levels for prediction and use in clinical practice, a larger prospective follow-up study is needed. 
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Introduction
Wheezing in infancy is very common, about 
1/3 of infants experiencing at least one wheezing 
episode by their third birthday, and half of them 
by their sixth birthday. However, not all infants 
who experience wheezing continue to wheeze. 
Approximately one half of those wheezing be-
fore 3 year of age are asymptomatic by age of 6. 
The long-term prognosis of early wheezing is, 
in most cases, good. The vast majority of early 
wheezers either wheezes no more after the age 
of 3 years (early remittent wheezers) or only in 
some years (early intermittent wheezers) up to 
the age of 13 yrs. Only a very small fraction of 
early wheezers (early persistent wheezers) keeps 
on wheezing every single year up to the age of 
13 years [1, 2]. At present, it is not understood 
why wheezing illness persists in some children, 
when in most it resolves spontaneously.
It is apparent that infants and preschool 
children that wheeze with viral infections may 
have persistent symptoms and progress to develop 
asthma by school age. A major pediatric issue is 
how to identify the infants whose wheezing repre-
sents transient reactions in response to different 
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respiratory infections, and to distinguish those 
children from those whose wheezing represents 
the initial phase of persistent asthma. Findings 
to date strongly suggest that the impact of infant 
viral infections on the maturing of immune sys-
tem and developing lung, that subsequently result 
in an asthma phenotype occur during a critical 
susceptibility period, and in a genetically suscep-
tible host. There are currently no therapeutic stra-
tegies that allow prevention of asthma following 
early life viral respiratory infections in high-risk 
children, thus a focus on understanding the me-
chanisms of progression from viral wheezing in 
infants and preschool children to asthma deve-
lopment are urgently needed [3].
The immune response, in particular T cell 
responses are known to play a key role in the de-
velopment of viral-induced wheeze. However, the 
pattern of cytokine response in wheezing infants 
is not clear. Th1 lymphocyte cytokine production 
(interferon-g and interleukin-2) is responsible for 
the cell-mediated immune response. Th2 lym-
phocyte cytokine production (interleukin-4 and 
interleukin-6) stimulates antibody production, 
especially IgE response, also enhancing eosino-
phil production and activity. Some studies are 
indicating that either Th1 or Th2 responses may 
predominate in infants with acute bronchiolitis, 
other studies, however, have reported that there 
is no specific Th1 or Th2 pattern of response in 
infants with this disease [4, 5]. One recent study 
demonstrated, that persistently increased produc-
tion of TNF-a in response to LPS stimulation of 
blood mononuclear cells at birth and at 3 months 
(not later) is predictive of the development of 
childhood asthma [6]. We undertook this study 
in order to determine whether plasma cytokine 
levels during the acute wheezing illness in infants 
are associated with the subsequent development 
of persistent recurrent wheezing. 
Material and methods
We conducted an observational prospective 
cohort study in 2009−2012. Infants between three 
month and three years of age admitted to Iashvili 
Central Children Hospital, Tbilisi, Georgia, with 
acute wheezing were selected for the study. 
The Ethics Committee at Tbilisi State Medi-
cal University approved the study and informed 
consent was obtained from the parents prior to 
enrolment.
Inclusion criteria were patients aged > 3 
month and < 3 years with a respiratory symptom 
duration of < 3 days. Respiratory symptoms inc-
lude prodromal rhinorrhea and cough, followed 
by at least 2 of the following signs: tachypnea, 
wheezing, rales, use of accessory muscles, and/or 
nasal flaring. Additional inclusion criteria inc-
luded first episode of wheezing or shortness of 
breath, and informed consent. 
Infants with extended crepitations on au-
scultation and bronchopneumonic infiltration in 
postero-anterior lung X-ray without sibilant rhon-
chi and prolongation in expiration were defined 
as pneumonia and were excluded from the study. 
Infants which were administered antihistamines 
and corticosteroids in any form during current 
illness were also excluded from the study. 
Baseline observations including temperature, 
oxygen saturation, respiratory and pulse rates 
were recorded at the time of admission and da-
ily thereafter in all participants. Total leukocyte 
counts with differential and C-reactive protein 
(CRP) levels were studied in all patients. Chest 
radiographs of all cases were evaluated by a pe-
diatric radiologist.
Samples of blood sera were obtained within the 
first 48 h of admission. The concentrations of IFN-g, 
TNF-a (TH1) and IL-6 (TH2) were determined by 
enzyme-linked immunosorbent assay (ELISA), 
with a detection limit of 25.0, 6.0 and 30.0 pg/ml, 
respectively. Results were considered to be ne-
gative when cytokine concentrations were below 
the detection limit. Total serum IgE level was 
also determined. Acute and convalescent serum 
samples were tested by ELISA for IgM and IgG 
antibodies to Respiratory Syncytial Virus, Chlamy-
dophila pneumonia and Mycoplasma pneumonia 
(manufacturer Vircell Microbiologists, Spain). 
Positive results were defined by a significant anti-
body response in specific IgM or a 4-fold increase 
in IgG titer in paired serum samples. A positive 
infection was defined either in a single test or in 
paired sera taken 2−3 weeks apart.
Occurrences of subsequent wheezing were 
obtained from parental responses on questionna-
ires and/or during physicians’ assessment either 
in inpatient or outpatients settings. All cases of 
hospital admission were recorded. Date were 
collected 1, 2 and 3 years later after enrolment 
in the study. Those children who had 3 or more 
episodes of wheezing each year of follow up were 
considered as a persistent recurrent wheezers [7]. 
The results have been analyzed by the SPSS 
Statistics versions 16.0 (IBM Corp, Amonk, NY). 
All data were entered onto a dedicated database 
and checked for errors. Thirteen variables were 
chosen as being of special interest: (1) atopic 
dermatitis in the infant; (2) low maternal age 
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(less than 20 years); (3) low birth weight; (4) 
parental atopy; (5) household cigarette smoking; 
(6) exclusive breastfeeding up to 6 month of age; 
(7) sex; (8) serum level of IL-6; (9) serum level of 
IFN-g; (10) serum level TNF-a; (11) serum level 
of total IgE; (12) RSV etiology of wheezing; (13) 
atypical etiology (Chlamydophila pneumonia, 
Mycoplasma pneumonia) of wheezing. Each 
variable was entered separately into univariate 
models. Estimated logistic regression coefficients, 
standard errors, odds ratios, and p-value from the 
score test statistic on the significance for each 
variable’s  inclusion into each univariate model 
were calculated. P < 0.05 has been considered 
as significant difference. Frequencies were com-
puted without excluding missing answers, which 
were therefore counted as negative. Missing an-
swers were always lower than 5%. Associations 
between several variables of wheezing children 
were assessed. Results are presented as odds ra-
tios (ORs) and 95% confidence intervals (95% CI).
Patients were grouped according to pathogens 
in three groups: in group I patients with atypical 
pathogens — Chlamydophila pneumoniae and 
Mycoplasma pneumoniae were included; in 
group II there were patients with RSV; in group 
III there were patients with mixed-infections 
with Chlamydophila pneumoniae, Mycoplasma 
pneumoniae and Respiratory syncytial virus.
Results
Of 47 children enrolled in the cohort, 
43 (91%) had at least 1 follow-up contact during the 
three year period and were included in the study. 
Subject characteristics
The study group consisted of 43 patients with 
lower respiratory tract infection with wheezing. 
Distribution of the patients of this group accor-
ding their age is shown in Figure 1.
Median age of the patients was 13.8 months, 
twenty-seven patients (63%) were boys. Nine 
patients (20.9%) were born prematurely. Thir-
teen patients (30.2%) were on formula feeding 
up to 6 month of age. Eighteen patients (41.8%) 
had a positive family history of atopy. Thirty pa-
tients (69.7%) were under environmental tobacco 
exposure (smoking mother or father). None of 
the patients received ribavirin or systemic anti
-inflammatory agents, including corticosteroids 
before enrolment.
In the control group, 6 children were boys 
(60%), the median age was 14.8 months and 
2 controls (20%) were born prematurely. Five 
patients (50%) were on formula feeding up to 
6 month of age. Two patients (20%) had a positive 
family history of atopy. Six patients (60%) were 
under environmental tobacco exposure (smoking 
mother or father).
Out of 43 patients etiological diagnosis were 
established in 32 patients (74.4%). They were 
grouped according to pathogens in three groups: 
Group I involved 13 patients, who had either 
Chlamydophila  pneumoniae or Mycoplasma 
pneumoniae or their co infections. In this group 
the median age was 13.7 month (age range from 
4 to 36 months).
Group II involved 10 patients with RSV, their 
median age was 12.6 month (age range from 4 to 
30 months).
Group III involved 9 patients, who had co 
infections of Chlamydophila pneumoniae, My-
coplasma pneumoniae and RSV. Their median age 
was 10.2 month (age range from 4 to 18 months). 
Co-infection with two pathogens were detected 
in 7 (18.9%) samples, three pathogens in 2 (4.6%) 
sample. 
Out of 43 children no wheezing episodes after 
one years follow-up had two (4.6%) children, after 
two year nine (20.9%) and after three years fifteen 
(34.8%) children. Three and more episodes after 
one year follow-up had twenty (46.5%) children, 
after two years — nineteen (44.1%) and after three 
years — sixteen (37.2%) children (Fig. 2).
In children with persistent recurrent 
wheezing there was a tendency for the associa-
tion with male sex, bottle feeding and household 
cigarette smoking, although the relation was not 
significant.
Figure 1. Patients distribution by age (%)
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Figure 2. Wheezing episodes during three years of follow up period
Table 1.  Independent odds ratios and confidence intervals for the effects of each variables on the risk recurrent 
wheezing for the three year of follow up
Factor OR 95% CI p-value
Atopic dermatitis in the infant 1.591 0.395−6.407 0.512
Parental atopy 2.571 0.721−9.167 0.141
Household cigarette smoking 0.926 0.242−0.543 0.911
Exclusive breastfeeding up to 6 month of age 0.667 0.167−2.666 0.565
Low maternal age 2.614 0.584−11.694 0.200
Low birth weight 1.094 0.791–1.502 0.611
Sex 1.512 0.410−5.586 0.534
IL-6 2.083 0.588−7.383 0.252
IFN- g 0.500 0.080−2.841 0.428
TNF-a 8.75 1.656−46.237 < 0.005*
Total IgE 1.146 0.322−4.081 0.834
RSV etiology 1.167 0.274−4.976 0.835
CPN etiology 2.614 0.584−11.694 0.200
MPN etiology 0.659 0.144−3.021 0.590
IL-6 — interleukin-6; IFN-g — interferon gamma; TNF-a — tumor necrosis factor-alpha; IgE — immunoglobulin E; RSV — respiratory syncytial virus; CPN — Chlamy-
dophila pneumoniae; MPN — Mycoplasma pneumoniae; *p < 0.05 considered significant
There was no significant association with 
atopy in the infant or parental atopy, low maternal 
age, low birth weight, serum level of IL-6, serum 
level of IFN-g and serum level of total IgE.
Persistent recurrent wheezing after three 
years of follow up also was not associated with 
the particular pathogens: there was no difference 
between RSV, Chlamydophila pneumonia and 
Mycoplasma pneumonia etiology of wheezing.
There was just TNF-a which was strongly 
associated with the risk of persistent recurrent 
wheezing after three years of follow up (OR = 
8.75; 95% CI 1.656-46.237, p < 0.05). TNF-a was 
not associated with specific etiology of infection. 
Independent odds ratios and confidence 
intervals for the effects of each variables on the 
risk of recurrent wheezing for the three years of 
follow up is shown in Table 1.
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Discussion
Evidence that early intervention with anti
-inflammatory agents leads to an amelioration of 
future disease is increasing, and the demand for 
rational treatment strategies for wheezing in in-
fancy is growing [8, 9]. It is clear, that it would be 
pointless to treat all wheezy infants as in most ca-
ses the condition will resolve spontaneously [10]. 
Therefore, an identifiable marker that would 
indicate whether an infant is likely to develop 
genuine asthma would be the most useful. Thus, 
the accurate selection of subjects in whom the 
benefits of early intervention outweigh the di-
sadvantages has become a most important issue 
[11, 12]. The identification of determinants for 
wheeze in early childhood has been the subject 
of several investigations [2, 3, 5, 13–18]. But, to 
the best of the author’s knowledge, this is the 
first study to quantify different factors, such as 
wheezing etiology (included atypical pathogens), 
demography, family history, household environ-
ment, feeding and pro- and anti-inflammatory 
cytokines level in early life to identify those 
markers, which might be predictive for the per-
sistence of wheezing later. 
Using univariate logistic regression, we fo-
und that children were more likely to experience 
persistent symptoms if, at presentation, they have 
elevated levels of TNF-a. There was a tendency for 
the association of recurrent wheezing with male 
sex, bottle feeding and household cigarette smo-
king, although the relation was not significant. 
There was no significant association with atopy 
in infant or parental atopy, low maternal age, low 
birth weight, serum level of IL-6, serum level of 
IFN-g and serum level of total IgE. 
In the majority of papers no significant corre-
lations were observed between the level of IL-6, 
IFN-g and recurrent wheezing [4, 6, 9], but in 
other studies IFN-g level was significantly higher 
among patients with recurrent wheezing  than 
among those without recurrent wheezing [8, 19].
In our study we found a direct correlation 
of TNF-a level with the development of recur-
rent wheezing later in life. The same results were 
showed in other studies, but not at the same age — 
in patients under 3 months [6, 20]. So, in spite of 
that our study is not the first study to suggest that 
TNF-a is related to asthma, it is the first study to 
show prospectively a relation of early-life TNF-a 
 to persistency of wheezing and asthma later. 
These results suggest that TNF-a could be 
considered as molecular predictor for recur-
rent  wheezing.  Only TNF-a (and not IL-6 or 
IFN-g) showed a significant relation to recurrent 
wheezing by logistic regression. This specificity 
raises the possibility that TNF-a may have a pre-
ferential or even unique biologic role in asthma 
development. Although asthma is most often not 
diagnosed until age 6, this does not mean that the 
process is not initiated much earlier in life. It is 
also possible that the relation of TNF-a to asthma 
does not have a direct biologic basis and simply 
serves as a biomarker [6]. 
We have not found significant association 
between birth weight and recurrent wheezing. 
Sonnenschein-van der Voort et al. [21] performed 
an individual participant data meta-analysis of 
147,252 children in 31 birth cohort studies to 
determine the associations of birth and infant 
growth characteristics with the risks of preschool 
wheezing and school-age asthma. Compared 
with children with a normal birth weight, those 
with a  low birth weight (less than 2500 g) had 
an increased risk of preschool wheezing and 
school-age asthma, but the associations of lower 
birth weight with childhood asthma were largely 
explained by gestational age at birth. Tadaki H. 
et al. [22] investigated cord blood cytokines  in 
a prospective birth cohort, intensively monitored 
for wheezy infant outcome at 1 yr. It was found out 
that risk of wheezing was related to birth weight, 
as well as cesarean section, and maternal eczema. 
Jaakkola et al. [23] performed a meta-analysis on 
the associations of preterm birth with asthma 
based on 19 published cohort, case control, and 
cross-sectional studies. They observed that pre-
term born children, which were defined as those 
born before 37 weeks of gestation, had an increased 
risk of asthma between 1 and 24 years of age, with 
a similar effect estimate as observed in our group of 
5- to 10-year-olds. They did not assess associations 
of birth weight with asthma outcomes. 
Although follow-up of this group continues 
and the whole group will be reevaluated clinically 
at 6 years of age, the length of follow-up reported 
in our study is 3 years. If, at the beginning of 
wheezing in children, it could be predicted that 
disease would continue for 3 years, the majority of 
physicians would regard more frequent follow-up 
and prophylactic treatment as being appropriate. 
Although an exact diagnosis of asthma will 
not be possible until 6 year of age or older, there 
is a need to identify which children have higher 
risk of asthma development that early interven-
tion studies can be planned. The identification 
of the high persistent production of this cytokine 
as a biomarker could provide a major advance in 
therapeutic design of prevention strategies.
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Conclusion
In conclusion, we have identified TNF-a, as 
a biomarker, which can be detected in age under 
3 years and may be useful in the prediction of 
persistence of wheezing later. To further evalu-
ate the usefulness of this and other markers and 
establish cutoff levels for prediction and use in 
clinical practice, a larger prospective follow-up 
study is needed. 
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